A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

There has been a tremendous growth in percutaneous coronary interventions (PCIs) with stent implantation, even in cases where coronary artery bypass grafting (CABG) demonstrates superior long-term ...

PARIS, France—It’s not a stent in a traditional sense, nor a scaffold that completely disappears over time, but a new device—one that “unchains” itself over time—has cleared an early hurdle by proving ...

Next-generation vascular stents can make cardiovascular therapies minimally invasive and vascular treatments safe and less ...

Mar. 24 -- FRIDAY, Feb. 22 (HealthDay News) -- To stent or not to stent? Which type of the artery-opening device is best? When is heart bypass surgery smarter than getting a stent? These are the ...

XIENCE Xpedition™ 48 Leverages Proven Design and Clinical Outcomes of the XIENCE Family of Drug Eluting Stents Has the Potential to Reduce Overall Procedural Costs Very Long Lesions Most Often Seen in ...

Please provide your email address to receive an email when new articles are posted on . A novel stent for treating long coronary lesions met its primary performance goal at 1 year. The 48-mm stent was ...

DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stents Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Global Coronary Stents Market was valued at ...

Cardiovascular diseases constitute a major global health concern. Various complications that affect normal blood flow in arteries and veins, such as ...

Vitamin therapy to lower homocysteine levels has recently been recommended for the prevention of restenosis after coronary angioplasty. We tested the effect of a combination of folic acid, vitamin B 6 ...

Cardiologists are speaking out against a Lown Institute report that alleged 1 in 5 stents placed in Medicare recipients were considered “overuse,” Medscape reported Dec. 20. The October report looked ...